Croup: why one dose of steroid is the standard treatment

Croup is a common viral infection of the upper airway that gives young children a barking cough, a hoarse voice and noisy breathing (stridor); in most children the symptoms subside within about two days [s1]. The single treatment with the strongest evidence is a one-off dose of an oral steroid — dexamethasone — which reduces symptoms and return visits to care even in mild cases, and the trial evidence now suggests a low dose works about as well as the traditional high one [s2][s3].

What croup is, and who gets it

Croup usually strikes between six and 36 months of age, peaking in the second year of life, and is somewhat more common in boys than girls [s1]. The commonest cause is parainfluenza virus, types 1 to 3 [s1]. The illness starts like an ordinary cold, with low-grade fever and a runny nose, before the swelling of the voice-box and windpipe produces the characteristic seal-like cough and stridor [s1]. Reassuringly, it is usually mild: only 1 to 8 percent of children with croup require hospital admission, and fewer than 3 percent of those admitted need intubation [s1]. That is the context for treatment — most croup gets better on its own, so the question is what safely speeds recovery and keeps children out of hospital.

The core evidence: steroids work

The mainstay is a single dose of a glucocorticoid, and the pooled trial evidence is substantial. A Cochrane review brought together 45 randomised controlled trials of 5,888 children [s2]. Compared with placebo, glucocorticoids reduced croup-severity scores two hours after treatment (standardised mean difference −0.65, 95% confidence interval −1.13 to −0.18; 7 trials, 426 children) and again at six hours (standardised mean difference −0.76, 95% CI −1.12 to −0.40) [s2]. The reviewers rated most of the underlying studies as at high or unclear risk of bias, so the certainty is graded low — but the direction and consistency of benefit is clear, and serious harms were rare [s2].

The benefit is not confined to severe cases, which is the counter-intuitive part. A double-blind trial randomised 720 children with mild croup — a score of 2 or less on the Westley scale — to a single oral dose of dexamethasone (0.6 mg per kilogram) or placebo [s3]. Return to a medical provider within seven days fell from 15.3 percent with placebo to 7.3 percent with dexamethasone (P<0.001), and treated children had quicker resolution of symptoms, lost less sleep and caused their parents less stress [s3]. The effects were small per child but consistent, and the trial's authors concluded the data support treating most, if not all, children with croup [s3].

How much, and which steroid

Two practical questions follow, and recent evidence has sharpened both answers. On dose, guidance has long recommended a single dose of dexamethasone in the range of 0.15 to 0.60 mg per kilogram, usually given by mouth [s1]. The Cochrane update's notable conclusion is that the smaller 0.15 mg/kg dose may be as effective as the standard 0.60 mg/kg: across dose comparisons there was little to no difference in return visits or readmissions (risk ratio 0.91, 95% CI 0.71 to 1.17; 3 trials, 949 children) [s2]. On which steroid, prednisolone and dexamethasone came out much the same for symptom control at two hours (standardised mean difference 0.06, 95% CI −0.06 to 0.18; 1 trial, 1,231 children) [s2]. For the minority of children with moderate-to-severe croup, nebulised epinephrine is an accepted additional treatment that acts fast while the steroid takes effect [s1]. Doses and drug choices here are clinical decisions, not something to self-administer; this article is informational.

Where croup sits among childhood illnesses

Croup is one of several common childhood conditions where the honest evidence-based answer is to do less, not more — an instinct we trace in ear infections and the case for watchful waiting and in why antibiotics do nothing for colds. The noisy breathing of croup can also be confused with the wheeze of childhood asthma, which is a different problem with a different treatment; stridor that is severe, constant, or accompanied by drooling or difficulty swallowing points away from ordinary croup and toward an emergency.

How to read this

The evidence here is unusually settled at its core: steroids shorten croup and reduce return visits, and they help even mild cases [s2][s3]. What has moved is the detail — a low dose appears to do the job, and the choice between dexamethasone and prednisolone matters little [s2]. Set against a disease that is mild in the great majority and resolves in days, that is a strong, proportionate treatment [s1]. This article is informational and is not medical advice; a child who is struggling to breathe, drooling, or has stridor at rest needs urgent medical assessment.